Mark Howard Snyder - 16 Feb 2026 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF LEGAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
16 Feb 2026
Net transactions value
-$720,362
Form type
4
Filing time
17 Feb 2026, 18:53:47 UTC
Previous filing
11 Feb 2026
Next filing
24 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 17 Feb 2026 0001902866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +4,796 +14% $0.000000 38,977 16 Feb 2026 Direct
transaction HALO Common Stock Tax liability $205,511 -2,587 -6.6% $79.44 36,390 16 Feb 2026 Direct F1
transaction HALO Common Stock Options Exercise $0 +12,016 +33% $0.000000 48,406 16 Feb 2026 Direct
transaction HALO Common Stock Tax liability $514,851 -6,481 -13% $79.44 41,925 16 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -4,796 -50% $0.000000 4,796 16 Feb 2026 Common Stock 4,796 $0.000000 Direct F3
transaction HALO Performance Stock Units Options Exercise $0 -12,016 -100% $0.000000 0 16 Feb 2026 Common Stock 12,016 $0.000000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,587 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 6,481 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F4 This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.